Evidence map›Paper›PMID 25297064›Full record

Trial reportClinical pediatrics2015

Effect of an α-lactalbumin-enriched infant formula supplemented with oligofructose on fecal microbiota, stool characteristics, and hydration status: a randomized, double-blind, controlled trial.

Susan Wernimont, Robert Northington, Martin J Kullen, Manjiang Yao, Jodi Bettler

Registry-linked trialOpen access · hybridAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Clinical pediatrics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02658500 (Short and Long Term Effect of Early Infant Feeding and Nutritional Status on the Children's Health), which is not on this map. Cited by 18 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 3 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02658500 naunknown statusnot on this map

Short and Long Term Effect of Early Infant Feeding and Nutritional Status on the Children's Health

TypeinterventionalSponsorBeijing Sanyuan Foods Co LtdRan2014 to 2016Enrolled300ConditionsHealth BehaviorArmsInfant Formula, breast milk
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 3 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Susan WernimontNestlé Nutrition, King of Prussia, PA, USA susan.wernimont@rd.nestle.com.
Robert NorthingtonNestlé Nutrition, King of Prussia, PA, USA.
Martin J KullenDuPont Nutrition & Health, Wilmington, DE, USA.
Manjiang YaoNestlé Nutrition, King of Prussia, PA, USA.
Jodi BettlerNestlé Nutrition, King of Prussia, PA, USA.
Nestlé (United States) · USDuPont (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo evaluate the impact of oligofructose (OF)-supplemented infant formula on fecal microbiota, stool characteristics, and hydration.

methodsNinety-five formula-fed infants were randomized to α-lactalbumin-enriched control formula (CF) or identical formula with 3.0 g/L OF (EF) for 8 weeks; 50 infants fed human milk (HM) were included.

resultsEighty-four infants completed the study, 70 met per-protocol criteria. Over 8 weeks, bifidobacteria increased more in EF than CF group (0.70 vs. 0.16 log10 bacterial counts/g dry feces, P = .008); EF was not significantly different from HM group (P = .32). EF group stool consistency was intermediate between CF and HM groups; at week 8, EF group had softer stools than CF (5-point scale: 1 = hard, 5 = watery; consistency score 3.46 vs. 2.82, P = .015) without significant differences in stool frequency. Physician-assessed hydration status was normal for all infants.

conclusionsInfant formula with 3.0 g/L OF promoted bifidobacteria growth and softer stools without adversely affecting stool frequency or hydration.

Indexed as

Food, FortifiedBody WaterDouble-Blind MethodFecesFemaleHumansInfant FormulaInfant, NewbornLactalbuminMaleMicrobiotaOligosaccharidesProspective StudiesLactalbuminoligofructoseOligosaccharidesbifidobacteriahydrationinfant formulamicrobiotaoligofructoseprebioticstool consistencystool frequencyα-lactalbumin

Identifiers

PMID25297064
PMCPMC4370932
OpenAlexW2098371977

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.